Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms

Dissolution tests are used for many purposes in the pharmaceutical industry: in the development of new products, for quality control and, to assist with the determination of bioequivalence. Recent regulatory developments such as the Biopharmaceutics Classification Scheme have highlighted the importance of dissolution in the regulation of post-approval changes and introduced the possibility of substituting dissolution tests for clinical studies in some cases. Therefore, there is a need to develop dissolution tests that better predict the in vivo performance of drug products. This could be achieved if the conditions in the gastrointestinal tract were successfully reconstructed in vitro. The aims of this article are, first, to clarify under which circumstances dissolution testing can be prognostic for in vivo performance, and second, to present physiological data relevant to the design of dissolution tests, particularly with respect to the composition, volume, flow rates and mixing patterns of the fluids in the gastrointestinal tract. Finally, brief comments are made in regard to the composition of in vitro dissolution media as well as the hydrodynamics and duration of the test.

[1]  J. Cummings,et al.  Evidence for the mixing of residue in the human gut. , 1976, Gut.

[2]  J. Elashoff,et al.  Human postprandial gastric emptying of 1-3-millimeter spheres. , 1988, Gastroenterology.

[3]  R. Hinder,et al.  Canine gastric emptying of solids and liquids. , 1977, The American journal of physiology.

[4]  Jindřich Kopeček,et al.  Hydrogels for Site-Specific Drug Delivery to the Colon: In Vitro and in Vivo Degradation , 1992, Pharmaceutical Research.

[5]  A. Beezer,et al.  In vitro dissolution testing of oral controlled release preparations in the presence of artificial foodstuffs. I: Exploration of alternative methodology: microcalorimetry , 1989 .

[6]  J. Dressman,et al.  Mixing-tank model for predicting dissolution rate control or oral absorption. , 1986, Journal of pharmaceutical sciences.

[7]  P. Christiansen.  The incidence of achlorhydria and hypochlorhydria in healthy subjects and patients with gastrointestinal diseases. , 1968, Scandinavian journal of gastroenterology.

[8]  P. McHugh,et al.  Regulation of the gastric emptying of glucose. , 1983, Gastroenterology.

[9]  G. Vantrappen,et al.  Bile acid output and the interdigestive migrating motor complex in normals and in cholecystectomy patients. , 1980, Gastroenterology.

[10]  Nobuo Aoyagi,et al.  Estimation of Agitation Intensity in the GI Tract in Humans and Dogs Based on in Vitro/in Vivo Correlation , 1995, Pharmaceutical Research.

[11]  L. Lesko,et al.  flP Guidelines for Dissolution Testing of Solid Oral Products Joint Report of the Section for O"icial laboratories and Medicines Control Services and the Section of Industrial Pharmacists of the FIP , 1997 .

[12]  M. Rautureau,et al.  [Bile salts and lipids in aqueous intraluminal phase during the digestion of a standard meal in normal man (author's transl)]. , 1981, Gastroenterologie clinique et biologique.

[13]  O. Fausa,et al.  Duodenal bile acids after a test meal. , 1974, Scandinavian journal of gastroenterology.

[14]  J. Moppert,et al.  Gastrointestinal transit of Oros drug delivery systems in healthy volunteers: a short report. , 1985, British journal of clinical pharmacology.

[15]  B. Borgström,et al.  Studies of intestinal digestion and absorption in the human. , 1957, The Journal of clinical investigation.

[16]  T. Almy.  The first olive. , 1982, Gastroenterology.

[17]  A. Tangerman,et al.  Analysis of conjugated and unconjugated bile acids in serum and jejunal fluid of normal subjects. , 1986, Clinica chimica acta; international journal of clinical chemistry.

[18]  C. Samyn,et al.  Azo polymers for colon-specific drug delivery , 1992 .

[19]  J. Fordtran,et al.  Volume-Flow Relationship During the Transport of Fluid Through the Human Small Intestine , 1965 .

[20]  A. Hofmann,et al.  Nocturnal gallbladder storage and emptying in gallstone patients and healthy subjects. , 1978, Gastroenterology.

[21]  R. Coleman,et al.  Gastric emptying of varying meal weight and composition in man , 2005, Digestive Diseases and Sciences.

[22]  Clive G. Wilson,et al.  A comparative study of the gastrointestinal transit of a pellet and tablet formulation , 1984 .

[23]  Michael A. Koupparis,et al.  Dissolution of 4 controlled-release theophylline formulations in milk , 1987 .

[24]  G L Amidon,et al.  The influence of the interdigestive migrating myoelectric complex on the gastric emptying of liquids. , 1990, Gastroenterology.

[25]  J. Dressman,et al.  Upper Gastrointestinal pH in Seventy-Nine Healthy, Elderly, North American Men and Women , 1993, Pharmaceutical Research.

[26]  Blythe Rh,et al.  The formulation and evaluation of enteric coated aspirin tablets. , 1959 .

[27]  A. Zinsmeister,et al.  Relationship of motility to flow of contents in the human small intestine. , 1982, Gastroenterology.

[28]  P. Finholt,et al.  Dissolution kinetics of drugs in human gastric juice--the role of surface tension. , 1968, Journal of pharmaceutical sciences.

[29]  B. Palsson,et al.  Dissolution of lonizable Drugs in Buffered and Unbuffered Solutions , 1988, Pharmaceutical Research.

[30]  N. Kaniwa,et al.  Development and evaluation of a new peroral test agent GA-test for assessment of gastric acidity. , 1984, Journal of pharmacobio-dynamics.

[31]  J. Fordtran,et al.  Ionic constituents and osmolality of gastric and small-intestinal fluids after eating , 1966, The American Journal of Digestive Diseases.

[32]  J. Malagelada,et al.  Intestinal transit of solid and liquid components of a meal in health , 1984 .

[33]  L. Marzio,et al.  Gallbladder contraction and its relationship to interdigestive duodenal motor activity in normal human subjects , 1988, Digestive Diseases and Sciences.

[34]  J. Dressman,et al.  Estimation of the Increase in Solubility of Drugs as a Function of Bile Salt Concentration , 2004, Pharmaceutical Research.

[35]  H. Lennernäs,et al.  Regional Jejunal Perfusion, a New in Vivo Approach to Study Oral Drug Absorption in Man , 1995, Pharmaceutical Research.

[36]  J. Dressman,et al.  Upper Gastrointestinal (GI) pH in Young, Healthy Men and Women , 1990, Pharmaceutical Research.

[37]  J J Sidorov.  Intestinal absorption of water and electrolytes. , 1976, Clinical biochemistry.

[38]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[39]  G. Macfarlane,et al.  Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.

[40]  S. Davis,et al.  Alimentary tract andpancreas Transit ofpharmaceutical dosage forms through the , 1986 .

[41]  W. Nernst,et al.  Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen , 1904 .

[42]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[43]  J. Fell,et al.  The Gastric Emptying of Pellets Contained in Hard Gelatin Capsules , 1982 .

[44]  F. Hoelzel.  THE RATE OF PASSAGE OF INERT MATERIALS THROUGH THE DIGESTIVE TRACT , 1930 .

[45]  F. Deland,et al.  Rate and pattern of gastric emptying in humans using 99mTc-labeled triethylenetetraamine-polystyrene resin. , 1980, Journal of pharmaceutical sciences.

[46]  H. Brøndsted,et al.  Polymers for colon-specific drug delivery , 1992 .

[47]  Clive G. Wilson,et al.  Physiological pharmaceutics : biological barriers to drug absorption , 1989 .

[48]  M. Sarr,et al.  Canine jejunal absorption and transit during interdigestive and digestive motor states. , 1980, The American journal of physiology.